Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $9,356 - $10,608
195 New
195 $10,000
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $359,520 - $425,722
-5,250 Reduced 96.42%
195 $14,000
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $14,160 - $15,596
195 Added 3.71%
5,445 $426,000
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $11,988 - $14,375
-195 Reduced 3.58%
5,250 $387,000
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $10,457 - $12,191
195 Added 3.71%
5,445 $340,000
Q2 2021

Aug 06, 2021

SELL
$61.91 - $67.42 $442,656 - $482,053
-7,150 Reduced 57.66%
5,250 $348,000
Q1 2019

Oct 11, 2019

SELL
$45.12 - $53.8 $225,600 - $269,000
-5,000 Reduced 28.74%
12,400 $592,000
Q4 2017

Oct 11, 2019

SELL
$59.94 - $65.35 $248,751 - $271,202
-4,150 Reduced 19.26%
17,400 $1.07 Million
Q2 2017

Oct 11, 2019

SELL
N/A
-5,250 Reduced 19.59%
21,550 $1.2 Million
Q1 2017

Oct 11, 2019

BUY
N/A
10,250 Added 61.93%
26,800 $1.46 Million
Q4 2016

Oct 11, 2019

SELL
N/A
-7,150 Reduced 30.17%
16,550 $967,000
Q3 2016

Oct 11, 2019

BUY
N/A
7,150 Added 43.2%
23,700 $1.28 Million
Q2 2016

Oct 11, 2019

SELL
N/A
-29,900 Reduced 64.37%
16,550 $1.22 Million
Q1 2016

Oct 11, 2019

BUY
N/A
46,450
46,450 $2.97 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stonehage Fleming Financial Services Holdings LTD Portfolio

Follow Stonehage Fleming Financial Services Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.